Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Half-dose Ticagrelor Monotherapy Versus Standard Dual Antiplatelet Therapy in Chronic Coronary Syndrome After Percutaneous Coronary Intervention: a Randomised Pilot Trial With PRU-guided Pharmacodynamic Assessment

NCT07622056 is registered in ClinicalTrials.gov with Kaohsiung Veterans General Hospital. as lead sponsor.

NCT NCT07622056
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07622056 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Half-dose Ticagrelor Monotherapy Versus Standard Dual Antiplatelet Therapy in Chronic Coronary Syndrome After Percutaneous Coronary Intervention: a Randomised Pilot Trial With PRU-guided Pharmacodynamic Assessment
Lead sponsor
Kaohsiung Veterans General Hospital.
Phase
Phase 4
Overall status
Completed
Start date
January 3, 2024
Completion date
December 31, 2024
Enrollment
54 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronary heart disease